EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Overview Fund Activity
Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

169 hedge funds and large institutions have $947M invested in Eagle Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 80 increasing their positions, 37 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
169
Holders Change
-6
Holders Change %
-3.43%
% of All Funds
4.22%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.12%
New
34
Increased
80
Reduced
37
Closed
36
Calls
$7.68M
Puts
$5.85M
Net Calls
+$1.83M
Net Calls Change
-$5.84M

Top Buyers

1
PWAM
Park West Asset Management
California
+$29.9M
2
JIM
Jupiter Investment Management
United Kingdom
+$16.8M
3
State Street
State Street
Massachusetts
+$16.6M
4
LSV Asset Management
LSV Asset Management
Illinois
+$13.6M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$12.7M

Top Sellers

1
PAI
ProQuest Associates IV
Florida
-$217M
2
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
-$49.2M
3
RHJA
Rice Hall James & Associates
California
-$15.9M
4
RIM
Ranger Investment Management
Texas
-$12.4M
5
MCM
Matarin Capital Management
New York
-$8.16M
Name Holding Trade Value Shares
Change 		Shares
Change %
FIB
201
First Interstate Bank
Montana
– -$14K -180 Closed
5 6 7 8
9